– CLIA/COLA Compliant, Quality program initiated
– Comprehensive SOP’s, Employee Training Programs, Quality Systems and Protocols
– FDA Registration (No INDA or BLA needed for products)
– Initial Lab Started
– cGMP’s established
– Initial US, Europe, Japan and China patents filed
The purpose of this publication was to evaluate the clinical value of tendon needling with PRP in patients with chronic tennis elbow compared with an active control group.
“Systems for Autologous Biological Therapeutics”
– Hired Gary A. Peterson as President
– Hired Theodore T. Sand, PhD as VP of Research and Regulatory Affairs
– Initiated renewal of website
– European Patent EP 2685816 Granted
